The MHC class II deficiency syndrome: Heterogeneity at the level of the response to 5-azadeoxycytidine
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Research in Immunology
- Vol. 141 (2) , 129-140
- https://doi.org/10.1016/0923-2494(90)90132-i
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-XCell, 1988
- Regulation of Genes for HLA Class II Antigens in Cell Lines from Patients with Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1988
- DNA methylation and gene activityCell, 1988
- Differential expression of the HLA-DR genes in various melanoma cell lines treated with interferon-γ: Methylation of the HLA-DRα gene in these lines is not correlated with its expressionHuman Immunology, 1987
- A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genesNature, 1985
- Molecular analysis of the bare lymphocyte syndrome.Journal of Clinical Investigation, 1985
- The class II molecules of the human and murine major histocompatibility complexCell, 1984
- Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned cDNA probesCell, 1980
- Failure of lymphocyte-membrane HLA-A and -B expression in two siblings with combined immunodeficiencyClinical Immunology and Immunopathology, 1979
- Messenger RNA for myosin polypeptides: Isolation from single myogenic cell culturesCell, 1977